Wednesday, April 2, 2014

Actavis PLC Brand Biosimilar Drugs Drive Share Increase

Actavis PLC trades about 208.00 per share and is the one to watch.  Actavis PLC is a global, integrated specialty pharmaceutical company focused on developing, manufacturing, and distributing,  generic brand bio- similar products. 

Actavis is positioned to continue to expand its generic drug network to serve participating global markets.  Actavis just acquired Silom Medical Company and will improve its generic supply process across Thailand to strengthen company revenue.

Performance of Actavis PLC has improved since Watson Pharmaceuticals acquired Actavis Group in November 2012.  Share price advanced noticeably , following the announcement  that the company acquired Warner Chilcott, a specialty pharmaceutical firm.  This added to the Actavis selection of branded pharmaceutical products.

Technological advances have global partners expecting  a consistent operating generic drug supply network.  Consumers demand it, governmental structure supports it, and Actavis PLC can deliver it.  This stock is worth a watch.

Home Care Path celebrates 4 years of successfully serving seniors in South Central Wisconsin

 
 

 App  http://appsmakerstore.com/appim/j6kcdet8xvwk4s


Blog  http://homecarepathseniorcare.blogspot.com/

 Home Care Path  www.homecarepath.com and the Wisconsin PATH ALONG model deliver an advanced supportive care service.  Helping seniors in the home, with clinic visits, at the hospital, nursing home and assisted living facility.  Helping seniors downsize with a move in to an adult child's home. 2014 rates are 20.00 per hour.  Simply call 608-432-4286 to schedule an interview.  We can be there when you are working.  We accept long term care insurance.  Services can be tax deductible.  Help with resources and the transition from private payment to public funded programming.  Valuing home and human life

No comments:

Post a Comment